Fig. 8.
Overview of immune parameters in cancer patients. The immune abnormalities increased with the progression of disease when compared with the normal subjects (p < 0.0001). A total of 29 immune parameters were examined in normal, TN and HT. The numbers of immune abnormality compared to normal was significantly increased in HT (25/29) than in TN (3/29) suggesting that extensive treatment in cancer patients may be associated with more immune deficit